MANSFIELD, Mass.-- (BUSINESS WIRE)-- Covidien (NYSE:COV), a leading global provider of healthcare products, today released the results of the Solitaire™ FR Thrombectomy for Acute Revascularization ...
The Solitaire (TM) FR revascularization device has been cleared by the U.S. Food and Drug Administration and is intended to restore blood flow to the brain in patients suffering acute ischemic stroke ...
DUBLIN - April 30, 2019 - Medtronic plc (MDT) today announced the U.S. launch of the Solitaire(TM) X Revascularization Device - and its first use in patients for the treatment of acute ischemic stroke ...
Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the Solitaire TM FR Revascularization Device has been approved for investigational use in the Interventional ...
Both the SOLITAIRE™ FR With the Intention For Thrombectomy as PRIMary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) and Endovascular Revascularization With Solitaire Device Versus ...
Ischemic stroke, when blood clots block the blood vessels to the brain, represent about 87 percent of all strokes. Strokes affect 795,000 people in the U.S. each year. The highest death rates from ...
After snagging 510(k) clearance in March, Covidien ($COV) is bringing its Solitaire FR revascularization tech to Brazil, getting approval from that country's National ...
@FierceMedDev: Youngstown News, New motion-sensor technology eases debilitating pain of Boardman man. News via @vindicator. Story | Follow @FierceMedDev > The FDA has ...
Use of a mechanical revascularization device in patients with acute ischemic stroke is associated with good clinical outcome and low risk of procedure- and device-related complications, according to a ...
Two-Year Clinical Study Supports Safety and Efficacy of Covidien Solitaire™ FR Revascularization Dev
Two-Year Clinical Study Supports Safety and Efficacy of Covidien Solitaire™FR Revascularization Device STAR Study Reviews Device Use in Blood Clot Removal Treatment for Patients Experiencing Acute ...
Two-Year Clinical Study Supports Safety and Efficacy of Covidien Solitaire™ FR Revascularization Dev
STAR Study Reviews Device Use in Blood Clot Removal Treatment for Patients Experiencing Acute Ischemic Stroke Covidien's Solitaire FR device is designed to restore blood flow in patients experiencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results